CancerHumansSmall Cell Lung CarcinomaMaleFemaleLung Neoplasms
Overall survival according to time-of-day of immunochemotherapy for extensive-stage small cell lung cancer.
Zhe Huang, Zhaohui Ruan, Shidong Xu, Nachuan Zou, Li Deng, Huan Yan, Jiacheng Dai, Jun Deng, Xue Chen, Jing Wang, Hua Xiang, Liang Zeng, Gang Yin, Yongchang Zhang
Published: 202510.1002/cncr.70126
Abstract
BACKGROUND: Emerging evidence suggests that circadian timing influences the efficacy of immune checkpoint inhibitors (ICI), with morning infusions associated with improved therapeutic outcomes across various malignancies. However, the impact of ICI i…
Preview only. Read the full abstract at the source